Open access · US-GOV
via ClinicalTrials.gov Clinical trial
The Effects of Low Dose Naltrexone (LDN) on Diseases of Aging - A Retrospective Cross-sectional Study Into Off-label Use of LDN
Authors not listed
AgelessRx · 2022
Abstract
This retrospective, observational study will assess the health status of short- and long-term low-dose naltrexone (LDN) users.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-07-02 MST
Cite this
APA
Anonymous. (2022). The Effects of Low Dose Naltrexone (LDN) on Diseases of Aging - A Retrospective Cross-sectional Study Into Off-label Use of LDN. <em>AgelessRx</em>. https://clinicaltrials.gov/study/NCT05307627
Vancouver
Anonymous. The Effects of Low Dose Naltrexone (LDN) on Diseases of Aging - A Retrospective Cross-sectional Study Into Off-label Use of LDN. AgelessRx. 2022.
BibTeX
@misc{anon2022TheEff,
title = {The Effects of Low Dose Naltrexone (LDN) on Diseases of Aging - A Retrospective Cross-sectional Study Into Off-label Use of LDN},
author = {Anonymous},
journal = {AgelessRx},
year = {2022},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.